Target Name: MIR652
NCBI ID: G724022
Other Name(s): MIRN652 | hsa-mir-652 | microRNA 652 | hsa-miR-652-3p | MicroRNA 652 | hsa-miR-652-5p

MIR652: A Potential Drug Target and Biomarker

MIR652, also known as MIRN652, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases, including cancer. MIR652 is a small molecule that can interact with several protein molecules, including the nuclear receptor TRPV1. This interaction between MIR652 and TRPV1 has led to the idea that MIR652 could be a drug target.

The TRPV1 receptor is a G protein-coupled receptor that plays a role in sensory perception, including pain, temperature, and pleasure. MIR652 has been shown to interact with TRPV1 and can modulate its activity. This interaction between MIR652 and TRPV1 makes MIR652 a potential drug target.

One of the challenges in drug development is identifying biomarkers that can be used to predict the effectiveness of a drug. MIR652 has the potential to serve as a biomarker because it can be used as a target for drugs that interact with TRPV1. This means that drugs that target TRPV1 could potentially be more effective in treating diseases associated with high TRPV1 activity, such as cancer.

In addition to its potential as a drug target, MIR652 has also been shown to have other potential applications as a biomarker. For example, MIR652 has been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that MIR652 could be a useful biomarker for detecting the early stages of these cancers.

Another potential application of MIR652 as a biomarker is its ability to be targeted with small molecules. MIR652 is a small molecule, which means it can be easily synthesized and administered to patients. This makes it a promising candidate for use as a biomarker or drug target.

In conclusion, MIR652 is a promising candidate as a drug target and biomarker. Its interaction with TRPV1 and ability to be targeted with small molecules make it a promising target for drug development. Further research is needed to fully understand the potential of MIR652 as a drug and biomarker.

Protein Name: MicroRNA 652

More Common Targets

MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791